U.S. Food Stock News

Cogent Communications Holdings (CCOI) has drawn investor attention after the stock fell about 10% in the latest session and is now down roughly 23% over the past month. See our latest analysis for Cogent Communications Holdings. The recent slide builds on a weaker trend, with the share price down over the past quarter and the 1 year total shareholder return also declining sharply. This suggests sentiment has cooled and investors may be reassessing Cogent Communications Holdings' risk and...

In late May 2026, CNBC’s Jim Cramer highlighted SELLAS Life Sciences Group on “Mad Money,” calling the biotech a “great spec” and giving it “two thumbs up,” while investors tracked progress in its Phase 3 REGAL trial for GPS in AML patients in remission but ineligible for stem cell transplant. Attention is also building around SELLAS’ second AML candidate, SLS009, with upcoming topline data viewed as a potentially important catalyst for the company’s development pipeline. With recent returns...

In late May 2026, ZenaTech announced the early-stage development of ZenaWorx, a LiDAR-based virtual design and construction progress monitoring software that combines its Drone as a Service and Enterprise SaaS capabilities to support large-scale AI data center projects. By using drone-captured LiDAR to generate detailed 3D site maps and standardized analytics, ZenaWorx aims to become a core digital layer for tracking construction performance and design deviations across complex builds. We’ll...

Recent commentary on Proto Labs highlights muted revenue growth and falling earnings per share over recent years, raising questions about the company’s demand trends and profitability as of early 2026. Analysts are increasingly focused on Proto Labs’ below-average returns on capital and relatively high valuation multiple, which together suggest the market is paying a premium despite these operational headwinds. Next, we’ll examine how concerns over muted revenue growth and declining earnings...

In late May 2026, ICON plc reported full-year 2025 results showing sales of US$8.25 billion, a sharp drop in net income to US$229.34 million, disclosed multi-year revenue recognition issues, completed a US$750.01 million buyback program, updated 2026 revenue guidance to US$7.85–8.15 billion, and announced several board changes. While ICON is working through accounting control weaknesses and lower profitability, management highlighted strong Q4 2025 net bookings growth, a focus on...

Recent share performance and why investors are watching Parker-Hannifin Parker-Hannifin (PH) has drawn investor attention after a period of softer share performance, with the stock down over the past day, week, month, and three months, prompting fresh questions about how its fundamentals line up. See our latest analysis for Parker-Hannifin. Looking beyond the recent pullback, with the 90 day share price return down 14.57%, Parker-Hannifin’s 1 year total shareholder return of 29.03% and 3 year...

Recent price action and context Arcosa (ACA) has drawn fresh attention after recent trading saw the stock close at $126.75, with short term returns around 5% over the past week and mid single digit gains over the past month. See our latest analysis for Arcosa. That recent 5% 7 day share price return sits within a stronger run, with the share price up 14.9% over 90 days and year to date gains of 18.7%. The 1 year total shareholder return of 47.1% points to momentum that has been building...

What Dollar Tree’s latest earnings mean for investors Dollar Tree (DLTR) just posted first quarter results that came in ahead of market expectations, with higher sales, stronger comparable store performance, and earnings growth that led management to raise its full year outlook. See our latest analysis for Dollar Tree. The first quarter beat and raised outlook have pulled attention back to Dollar Tree, with a 7 day share price return of 22.6% and a 1 year total shareholder return of 27.6%...

Why CorVel Stock Is Drawing Attention Now Without a specific news catalyst in play, CorVel (CRVL) is attracting interest mainly because of its current valuation metrics, recent return pattern, and the scale of its workers’ compensation and claims management business. See our latest analysis for CorVel. Recent trading illustrates that CorVel’s 30 day share price return of 7.34% and 90 day share price return of 17.80% sit against a year to date share price decline of 6.07% and a 1 year total...

Quarterly results and guidance reset DICK'S Sporting Goods (DKS) reported first quarter revenue of US$5,164.5 million and net income of US$319.82 million, while at the same time trimming its full year net sales, operating income and earnings guidance. The company now projects full year net sales of US$22.1 billion to US$22.4 billion, operating income of US$1,688 million to US$1,806 million, and earnings per diluted share of US$13.27 to US$14.27. See our latest analysis for DICK'S Sporting...

On May 19, 2026, Gold.com, Inc. withdrew its May 15 shelf registration to issue 3,370,787 common shares, previously sized at $136.72 million. This reversal in capital-raising plans removes a potential near-term source of equity issuance, which could meaningfully alter expectations around financing and dilution. We will now examine how Gold.com’s withdrawn shelf registration, and its implications for future equity issuance, affect the company’s investment narrative. Uncover the next big thing...

In May 2026, IDEXX Laboratories expanded its Fecal Dx antigen testing to include taeniid tapeworms and integrated the SDMA kidney biomarker into Catalyst CLIPs for U.S. and Canadian veterinary customers at no additional cost. These upgrades deepen IDEXX’s role in earlier parasite and kidney disease detection, potentially increasing the clinical reliance on its diagnostic platforms. Next, we’ll examine how embedding SDMA into Catalyst CLIPs may influence IDEXX’s investment narrative built...

Recent performance snapshot KalVista Pharmaceuticals (KALV) has drawn fresh attention after a strong stretch for the stock, with the price at US$26.87 and total return figures over the past year and past 3 months standing out. See our latest analysis for KalVista Pharmaceuticals. For context, the share price has shown strong momentum over the past year, with a 90 day share price return of 67.31% and a 1 year total shareholder return of 127.71%. However, the 5 year total shareholder return of...

In late May 2026, UiPath, Inc. reported first-quarter revenue of US$418.38 million, up from US$356.62 million a year earlier, and moved from a net loss of US$22.56 million to net income of US$22.53 million, delivering basic and diluted earnings per share of US$0.04 from continuing operations. Alongside its first-ever quarter of GAAP profitability and new revenue guidance for fiscal 2027, UiPath highlighted growing enterprise adoption of its AI-powered automation platform, even as one...

Dyne Therapeutics (DYN) has filed a Biologics License Application with the FDA for zeleciment rostudirsen, targeting Duchenne muscular dystrophy patients eligible for exon 51 skipping, and is seeking Accelerated Approval supported by clinical efficacy and safety data. See our latest analysis for Dyne Therapeutics. Recent product milestones around z-rostudirsen appear to be reflected in Dyne Therapeutics' short term momentum, with a 4.15% 1 day share price return and 11.28% 7 day share price...

In May 2026, ICU Medical, Inc. shareholders approved amendments to the company’s charter and bylaws that removed supermajority voting thresholds and granted investors holding at least 25% of voting power the ability to call special meetings, subject to detailed procedural requirements. This governance shift, alongside the defeat of a separate proposal for a 10% special-meeting right, signals rising shareholder influence while preserving meaningful safeguards around how and when investors can...

Why Donaldson Company (DCI) is on investors’ radar Donaldson Company (DCI) has drawn fresh attention after a stretch of weaker recent returns, with the stock down 1.8% over the past week, 5% over the past month, and 12% in the past 3 months. This pullback comes despite annual revenue of US$3.75b and net income of US$378.5m. These results are supported by its filtration businesses across Mobile Solutions, Industrial Solutions, and Life Sciences, which span construction, mining, transportation,...

Academy Sports + Outdoors recently opened three new stores in Altoona, Pennsylvania, and in North Knoxville and Morristown, Tennessee, extending its presence in those states and adding nearly 200 jobs. These openings, accompanied by community donations and loyalty-focused initiatives like the myAcademy Rewards Mastercard, highlight how physical expansion and customer engagement remain central to Academy’s long-term growth focus. We’ll now examine how this latest wave of store openings,...

Earlier in May 2026, Fanatics announced it will launch a new Fanatics American Express Card on the Amex network, rewarding cardholders with FanCash redeemable across Fanatics’ apparel, tickets, trading cards, collectibles, and experiences, while also becoming a Membership Rewards transfer partner so Amex members can convert points into FanCash. This partnership deepens American Express’s reach into sports fandom and experiential rewards, reinforcing its focus on differentiated loyalty...

In May 2026, Henry Schein, Inc. announced that William K. “Dan” Daniel became Independent Chairman of the Board, succeeding long-time leader Stanley M. Bergman, while shareholders also approved a proposal to adopt majority voting for director elections. This leadership transition, paired with management’s emphasis on a value-creation plan and operational improvements, highlights an increased focus on governance, efficiency, and innovation across Henry Schein’s business. Next, we’ll examine...

Kontoor Brands (KTB) is back in focus after Wrangler reunited with Molson Coors Beverage Company for a limited edition Coors Banquet x Wrangler collection built around country artist Chase Rice and festival season demand. See our latest analysis for Kontoor Brands. Those Wrangler and Lee collaborations come as Kontoor Brands’ share price sits at US$71.77, with the stock up 16.7% year to date on a share price basis and delivering a 96.69% total shareholder return over three years. This...

Raymond James Financial (RJF) has been in focus after recruiting a $2.8 billion advisory team from Commonwealth Financial Network, as well as reporting record client assets under administration and quarterly earnings that exceeded consensus estimates. See our latest analysis for Raymond James Financial. Despite recruiting new advisors and reporting record client assets, Raymond James Financial’s share price is down 12.34% year to date and 8.19% over 30 days, while its 5 year total shareholder...

In late May 2026, Tandem Diabetes Care filed a US$47.40 million shelf registration covering 3,260,000 common shares for an ESOP-related offering. Around the same time, shareholders approved bylaw changes allowing directors to be removed with or without cause, subtly shifting governance and control dynamics. Next, we'll examine how this ESOP-focused shelf registration may influence Tandem Diabetes Care's investment narrative and long-term capital planning. The future of work is here. Discover...

Recent performance snapshot for Flywire Flywire (FLYW) has drawn investor interest after a strong recent run, with the stock up about 14.6% over the past month and about 29% over the past 3 months, compared with a 49.2% total return over the past year. See our latest analysis for Flywire. With the share price at $16.04, Flywire’s 30 day share price return of 14.57% and 90 day return of 29.04% point to building momentum, even as the 3 year total shareholder return declined 48.79%. If Flywire’s...